<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00586378</url>
  </required_header>
  <id_info>
    <org_study_id>ITAC05</org_study_id>
    <nct_id>NCT00586378</nct_id>
  </id_info>
  <brief_title>Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study</brief_title>
  <acronym>Post-Ovatio</acronym>
  <official_title>Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ELA Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ELA Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this post-approval study is to confirm the safety and effectiveness of Ovatio
      DR and VR ICDs
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients free from complications</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Shock effectiveness for VT/VF</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">85</enrollment>
  <condition>Sudden Cardiac Death</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ovatio DR and Ovatio VR</intervention_name>
    <description>implantable cardioverter defibrillator</description>
    <other_name>Ovatio DR 6550 Dual-Chamber ICD</other_name>
    <other_name>Ovatio VR 6250 Single-Chamber ICD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidates will come from the investigator's general ICD population who meet any of
             the accepted indications for an ICD implant according to the &quot;ACC/AHA/ESC 2006
             Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention
             of Sudden Cardiac Death&quot; (Zipes et al., JACC Vol. 48, No. 5, Sept. 2006:1064-1108).

        Exclusion Criteria:

          -  Ventricular tachyarrhythmia that may have transient or reversible causes such as:
             acute myocardial infarction, digitalis intoxication, drowning, electrocution,
             electrolyte imbalance, hypoxia, sepsis, or unstable ischemic episodes

          -  Incessant tachyarrhythmia

          -  Implanted pacemaker

          -  Primary disorder of bradyarrhythmia or atrial tachyarrhythmia

          -  Of minor age

          -  Pregnant

          -  Participating in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark J Schwartz, MS</last_name>
    <role>Study Director</role>
    <affiliation>ELA Medical, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Baywood</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2008</study_first_posted>
  <last_update_submitted>March 1, 2012</last_update_submitted>
  <last_update_submitted_qc>March 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

